News from the healthcare data industry
Furthers Alira Health’s Commitment to Empower Patients on their Healthcare JourneyJanuary 25, 2022 09:00 AM Eastern Standard Time FRAMINGHAM, Mass.–(BUSINESS WIRE)–Alira Health (www.alirahealth.com), a global healthcare consulting and technology firm, announced that it has acquired Self Care Catalysts, Inc., a digital health company headquartered in Toronto, Canada. Self Care Catalysts…
January 26, 2022 07:05 AM Eastern Standard Time NEW YORK–(BUSINESS WIRE)–Flatiron HealthⓇ today announced a partnership with Japan’s National Cancer Center Hospital East (NCCHE) to build a real-world database of patients with gastro-intestinal cancers. “Insights from Flatiron’s U.S.-derived real-world data have brought important treatment alternatives to patients with cancer around the world,” said…
January 24, 2022 04:00 PM Eastern Standard Time SYDNEY–(BUSINESS WIRE)–Global healthcare data technology company, Prospection, and leading Asia-Pacific biotech specialist CRO, Novotech Health Holdings, announce a strategic partnership to combine the power of real world evidence and clinical trials to get medicines to patients faster. The partnership includes an investment by Novotech…
January 24, 2022 04:12 PM Eastern Standard Time WASHINGTON–(BUSINESS WIRE)–Today, the RWE Alliance submitted a substantial comment letter in response to the U.S. Food and Drug Administration (FDA) draft guidance on using electronic health records (EHRs) and medical claims data to support regulatory decision making across therapeutic areas. “We look forward to…
January 24, 2022 By Sebastian Moss IBM will sell its Watson Health business to global investment firm Francisco Partners. The transaction is expected to close in the second quarter of 2022 and is subject to customary regulatory clearances. Financial terms of the transaction were not disclosed, but Bloomberg reports a price tag of…
By Dr Nicola Davies Since 2020, the US Food and Drug Administration’s activities have centered around the response to the COVID-19 pandemic.1 The agency closed out 2021 with the approval of two oral antivirals for COVID-19 – Pfizer’s (NYSE: PFE) Paxlovid co-packaged nirmatrelvir and ritonavir tablets and Merck & Co’s…
by Natalie Missakian | Jan 23, 2022 1:25pm The future of cancer drug marketing will be about helping oncologists understand the complexities of precision medicine and how new advances in targeted therapies can help their specific patients. That means drug companies will need to focus less on the selling and more on the…
CAMBRIDGE, Mass., Jan. 21, 2022 /PRNewswire/ — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, today announced the acquisition of Advera Health Analytics, the leader in pharmacovigilance software and data for detection, management, and mitigation of drug safety concerns. The acquisition of Advera,…
Changes to the way medicines and other health technologies are evaluated by NICE for use in the NHS were approved by its Board yesterday (19 January 2022). 20 January 2022 The changes will come into effect early next month for new evaluations and will give patients earlier access to innovative…
Syapse will continue to identify, validate, and address discrepancies in real-world data, producing an accurate and fully contextualized narrative of a patient’s experience January 20, 2022 10:00 ET | Source: Syapse … SAN FRANCISCO, Jan. 20, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden…